Qlucore, a world leader in the development of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics. In order to finance the expansion Qlucore has recently finalized a rights issue of 400k Euros and is pleased to announce two new members of the Board. Qlucore has created a software platform for […]
ANN ARBOR, Mich. — Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. This number reflects the rapidly accelerating pace of genomic discovery, and stands in stark contrast […]
SAN DIEGO – SLAS 2020 – Biosero, Inc. will release new Green Button GoTM software products and features, as well as a version that is certified 21 CFR Part 11 compliant, at the 2020 Society for Laboratory Automation and Screening Conference (SLAS 2020) in San Diego, California. “You can have all the data in the world, but if you can’t visualize […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid analysis of complex genomic data to improve disease characterization and diagnosis, today announced the launch of Congenica Neuro™, a new application on its clinical decision support platform that facilitates faster, more accurate and comprehensive characterization and diagnosis of epilepsy and neurodevelopmental disorders. Collectively, around 300 million people […]
NEW YORK — Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs. The technology is expected to be capable of enumerating, screening, and scoring billions of synthetically feasible, virtual compounds supporting the identification and optimization of […]
Certara’s Simcyp® Simulator’s MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product. Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Galderma’s successful U.S. Food and Drug Administration (FDA) new […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]
CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its […]
Partnership will advance both firms’ positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. — Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye’s pioneering Orion computational platform into Redesign’s drug discovery platform. The practice of drug discovery has radically transformed […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
